Basics Caribou Biosciences, Inc. IPO Date: July 23, 2021 Sector: Healthcare Industry: Biotech Market Cap: $177.59M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 3.80% Avg Daily Range (30 D): $0.11 | 4.41% Avg Daily Range (90 D): $0.10 | 4.36% Institutional Daily Volume Avg Daily Volume: 1.12M Avg Daily Volume (30 D): 2.62M Avg Daily Volume (90 D): 1.57M Trade Size Avg Trade Size (Sh.): 136 Avg Trade Size (Sh.) (30 D): 101 Avg Trade Size (Sh.) (90 D): 131 Institutional Trades Total Inst.Trades: 508 Avg Inst. Trade: $1.76M Avg Inst. Trade (30 D): $.93M Avg Inst. Trade (90 D): $.87M Avg Inst. Trade Volume: .28M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.87M Avg Closing Trade (30 D): $9.15M Avg Closing Trade (90 D): $9.15M Avg Closing Volume: 301.18K     News Nov 3, 2025 @ 12:00 PM Caribou Biosciences Announces Positive Data from C... Source: Caribou Biosciences Oct 2, 2025 @ 5:00 PM CRISPR Therapies Clinical Trial Pipeline Shows Pot... Source: Delveinsight Sep 2, 2025 @ 10:00 AM Gene Editing Market to Surpass USD 15.46 Billion b... Source: Sns Insider Jul 25, 2025 @ 11:35 PM CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Inve... Source: Bragar Eagel & Squire, P.C. May 6, 2025 @ 8:00 PM Caribou Biosciences to Participate in the BofA Sec... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.7 $-.3 $-.58 Diluted EPS $-1.7 $-.3 $-.58 Revenue $ 9.3M $ 2.2M $ 2.67M Gross Profit $ $ $ Net Income / Loss $ -157.13M $ -27.55M $ -54.1M Operating Income / Loss $ -158.77M $ -29.4M $ -47.58M Cost of Revenue $ $ $ Net Cash Flow $ -20.83M $ -14.06M $ -4.22M PE Ratio